Zobrazeno 1 - 10
of 235
pro vyhledávání: '"P. L . Zinzani"'
Autor:
M Lacerda, R Nair, H Chang, N Goldschmidt, B Haverkos, H Hua, L Zinzani, D Strickland, E González
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S258- (2024)
Introduction: Epstein-Barr virus-positive (EBV +) lymphomas are a heterogeneous group of malignancies that harbor latent EBV within the lymphoma cells and are associated with variable clinical features. Outcomes of EBV + Peripheral T-Cell Lymphoma (P
Externí odkaz:
https://doaj.org/article/c726dde768a4451b8975296e27f16f2b
Autor:
M Lacerda, R Nair, H Chang, N Goldschmidt, B Haverkos, H Hua, L Zinzani, D Strickland, E González
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S258-S259 (2024)
Introduction: Patients with Epstein-Barr virus-positive (EBV+) lymphoma are currently faced with challenging outcomes and represent an unmet medical need. Clinical outcomes in this population may be inferior to the EBV– counterpart in different lym
Externí odkaz:
https://doaj.org/article/aef6c8bbf9af45d0b25c3c6d59e763c7
Autor:
Andrew D. Zelenetz, Wojciech Jurczak, Vincent Ribrag, Kim Linton, Graham P. Collins, Javier L. Jiménez, Mark Bishton, Bhagirathbhai Dholaria, Andrea Mengarelli, Tycel J. Phillips, Nagendraprasad Sungala, Gerardo Musuraca, Oonagh Sheehy, Eric Van Den Neste, Mitsuhiko Odera, Lu Miao, Daniel P. Gold, Richard G. Ghalie, Pier L. Zinzani
Publikováno v:
HemaSphere, Vol 8, Iss 8, Pp n/a-n/a (2024)
Abstract In this global phase 2 study in patients with relapsed/refractory follicular lymphoma (FL), zandelisib was administered on intermittent dosing to mitigate immune‐related adverse events and infections that have been reported with oral PI3K
Externí odkaz:
https://doaj.org/article/01ca8e0063d3415eb0c1d640ff74ac54
Autor:
Mark J. Bishton, Gilles Salles, Camille Golfier, Wolfgang Knauf, Monica Bocchia, Deborah Turner, Borhane Slama, Jatinder Harchowal, Scott Marshall, Alberto Bosi, Juan José Bargay Lleonart, Manfred Welslau, SooKyoung Kim, Young N. Lee, Pier L. Zinzani, Kamel Laribi
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 45-54 (2023)
Abstract The rituximab biosimilar CT‐P10 is approved for the treatment of non‐Hodgkin lymphoma. Previous studies have demonstrated clinical similarity between CT‐P10 and reference rituximab. However, real‐world data relating to treatment in p
Externí odkaz:
https://doaj.org/article/fe50306f84f445cd873e4e8c3079f682
Autor:
D. Noerenberg, F. Briest, C. Hennch, K. Yoshida, J. Nimo, R. Hablesreiter, Y. Takeuchi, D. Sasca, H. Ueno, L. Mansouri, Y. Inoue, L. Wiegand, A. M. Staiger, B. Casadei, M. Ziepert, F. Asmar, P. Korkolopoulou, M. Kirchner, P. Mertins, J. Weiner, E. Toth, T. Weber, A. Warth, T. Schneider, R.-M. Amini, W. Klapper, M. Hummel, V. Poeschel, G. Kanellis, A. Rosenwald, G. Held, E. Campo, K. Stamatopoulos, I. Anagnostopoulos, L. Bullinger, N. Goldschmidt, P. L. Zinzani, C. Bödor, R. Rosenquist, T. P. Vassilakopoulos, G. Ott, S. Ogawa, F. Damm
Publikováno v:
HemaSphere, Vol 6, Pp 2-3 (2022)
Externí odkaz:
https://doaj.org/article/d54a8cd5040e4d8d8fba3b1b3fbe8223
Autor:
A. Zelenetz, W. Jurczak, V. Ribrag, K. Linton, G. Collins, J. Lopéz-Jiménez, N. Reddy, A. Mengarelli, T. Phillips, G. Musuraca, O. Sheehy, J. Li, W. Xu, M. Azoulay, R. Ghalie, P. L. Zinzani
Publikováno v:
HemaSphere, Vol 6, Pp 109-110 (2022)
Externí odkaz:
https://doaj.org/article/a634be2cff8a4653bb963ad22e55ada0
Autor:
C. Carlo-Stella, S. Ansell, P. L Zinzani, J. Radford, K. Maddocks, A. Pinto, G. P. Collins, V. Bachanova, N. Bartlett, I. Bence-Bruckler, M. Hamadani, J. Kline, J. Mayer, K. J. Savage, R. Advani, P. Caimi, R.-O. Casasnovas, T. Feldman, B. Hess, M. Bastos-Oreiro, S. Iyengar, S. Eisen, Y. Negievich, L. Wang, J. Wuerthner, A. F. Herrera
Publikováno v:
HemaSphere, Vol 6, Pp 102-103 (2022)
Externí odkaz:
https://doaj.org/article/c408aca20b434dd29a4b8a446f057518
Autor:
J.-M. Michot, A. Mehta, F. Samaniego, E. Bachy, P. L. Zinzani, A. Prica, G. P. Colins, V Ribrag, N. Wagner-Johnston, D. El-Sharkawi, O. A. O’Connor, R. Wilcox, L. Wang, L. Wilson, M. Sims, J. A. Taylor, H. N. Keer, F. Foss
Publikováno v:
HemaSphere, Vol 6, Pp 118-119 (2022)
Externí odkaz:
https://doaj.org/article/c7bc99c59a4542cd9efad55873a78682
Autor:
P. L. Zinzani, J. Mayer, R. Auer, F. Bijou, A. C. de Oliveira, C. R. Flowers, M. Merli, K. Bouabdallah, P. S. Ganly, Y. Song, H. Zhang, R. Johnson, A. M García-Sancho, M. Provencio, M. Trněný, S. Yuen, H. Tilly, E. Kingsley, G. Tuyman, S. E. Assouline, E. Ivanova, P. Kim, J. Huang, R. Delarue, J. Trotman
Publikováno v:
HemaSphere, Vol 6, Pp 106-107 (2022)
Externí odkaz:
https://doaj.org/article/d5e9c841f48c483caa82b720f02f9ee4
Autor:
W. Jurczak, A. J. Alencar, G. S. Guru Murthy, M. Hoffmann, J. M. Pagel, V. Patel, J. M. Pauff, P. L. Zinzani, S. Le Gouill, A. R. Mato, L. E. Roeker
Publikováno v:
HemaSphere, Vol 6, Pp 579-580 (2022)
Externí odkaz:
https://doaj.org/article/3a5d3b016a0d4bef95d4bc62ad718999